Better not expect the latest medicine either...
Linky
"UK patients have been cut from an international clinical trial to test a new heart attack drug because of uncertainties about registering new medicines after Brexit.
The drug, dutogliptin, is being tested to see if it can help regenerate cardiac muscle after a heart attack and patients in Exeter, Leeds and Clydebank in Scotland were due to take part.
However Recardio, the US-based company developing the drug, has shelved the UK arm of the trial over fears that data in Britain will no longer be acceptable to the European Medicines Agency (EMA) – which licenses drugs for EU use – after Britain quits the bloc.